Galina Karabanovich

Development of 3,5-Dinitrobenzylsulfanyl-1,3,4-oxadiazoles and Thiadiazoles as Selective Antitubercular Agents Active Against Replicating and Nonreplicating<i>Mycobacterium tuberculosis</i>

Galina Karabanovich, Júlia Zemanová, Tomáš Smutný et al. · Journal of Medicinal Chemistry · 2016 · 112 citations · Full text

S-substituted 3,5-dinitrophenyl 1,3,4-oxadiazole-2-thiols and tetrazole-5-thiols as highly efficient antitubercular agents

Galina Karabanovich, Jan Němeček, Lenka Valášková et al. · European Journal of Medicinal Chemistry · 2016 · 65 citations

Medicinal Chemistry, Heterocyclic, Biochemistry +7

Development of 3,5-Dinitrophenyl-Containing 1,2,4-Triazoles and Their Trifluoromethyl Analogues as Highly Efficient Antitubercular Agents Inhibiting Decaprenylphosphoryl-β-<scp>d</scp>-ribofuranose 2′-Oxidase

Galina Karabanovich, Ján Dušek, Karin Savková et al. · Journal of Medicinal Chemistry · 2019 · 61 citations

Clinically Translatable Prevention of Anthracycline Cardiotoxicity by Dexrazoxane Is Mediated by Topoisomerase II Beta and Not Metal Chelation

Eduard Jirkovský, Anna Jirkovská, Hana Bavlovič Piskáčková et al. · Circulation Heart Failure · 2021 · 53 citations · Full text

1-Substituted-5-[(3,5-dinitrobenzyl)sulfanyl]-1H-tetrazoles and their isosteric analogs: A new class of selective antitubercular agents active against drug-susceptible and multidrug-resistant mycobacteria

Galina Karabanovich, Jaroslav Roh, Tomáš Smutný et al. · European Journal of Medicinal Chemistry · 2014 · 52 citations

Medicinal Chemistry, Bioorganic Chemistry, Medicine +13